Federal Circuit Affirms PTAB’s IPR Ruling Against Medtronic Over Catheter Patents

Mealey's (May 31, 2023, 1:52 PM EDT) -- WASHINGTON, D.C. — Affirming an inter partes review (IPR) ruling by the Patent Trial and Appeal Board (PTAB), a Federal Circuit U.S. Court of Appeals panel majority found that Medtronic Inc. did not establish that catheter guide patents in suit are unpatentable, agreeing with the board’s rejection of asserted prior art and its conclusion that a broader intended purpose for the patents was consistent with expert and inventor testimony....